Muehltal, Germany

Shaonan Wang

This inventor holds 1 USPTO granted patent. Top assignees: Merck Patent Gmbh, Pfizer Corporation. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shaonan Wang. Retrieved from https://idiyas.com/inventor/shaonan-wang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shaonan Wang - Innovator in Cancer Treatment

Introduction

Shaonan Wang is a notable inventor based in Muehltal-Traisa, Germany. He has made significant contributions to the field of cancer treatment through his innovative work. His expertise and dedication have led to advancements that could potentially improve patient outcomes.

Latest Patents

Shaonan Wang holds a patent for a dosing regimen of avelumab for the treatment of cancer. This invention focuses on an improved dosing regimen that aims to enhance the effectiveness of avelumab in treating cancer. His work in this area demonstrates a commitment to finding better therapeutic options for patients.

Career Highlights

Throughout his career, Shaonan Wang has worked with prominent companies in the pharmaceutical industry, including Pfizer Corporation and Merck Patent GmbH. His experience in these organizations has provided him with valuable insights and skills that have contributed to his success as an inventor.

Collaborations

Shaonan Wang has collaborated with notable professionals in his field, including Glen Ian Andrews and Carlo Leonel Bello. These partnerships have likely enriched his work and expanded the impact of his inventions.

Conclusion

Shaonan Wang is a dedicated inventor whose work in cancer treatment exemplifies innovation and commitment to improving healthcare. His contributions through patents and collaborations highlight his role in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…